mRS ≤2 (35.6%) | mRS 3–6 (64.4%) | p Value | |
---|---|---|---|
Women (%) | 39.7 | 47.9 | 0.65 |
Age | 69±13 | 73±12 | 0.05 |
Diabetes (%) | 15.3 | 20.2 | 0.43 |
Hypertension (%) | 57.6 | 69.7 | 0.12 |
Atrial fibrillation (%) | 35.6 | 49.5 | 0.08 |
Dyslipidemia (%) | 36.2 | 44.4 | 0.31 |
Glycemia | 122±29 | 137±42 | 0.05 |
Systolic BP | 139±30 | 149±34 | 0.07 |
Diastolic BP | 78±16 | 83±19 | 0.15 |
Intravenous tPA (%) | 72.1 | 52.3 | 0.01 |
Terminal ICA occlusion (%) | 20 | 47.3 | <0.01 |
Baseline NIHSS (IQR) | 17 (7) | 19 (4) | <0.01 |
Median ASPECTS (IQR) | 10 (1) | 10 (2) | <0.01 |
Symptomatic ICH (%) | 3.3 | 14.2 | 0.02 |
Time to groin puncture (min) | 197±74 | 233±95 | 0.02 |
Time to recanalization (min) | 280±79 | 341±128 | <0.01 |
Recanalization (TICI ≥2b, %) | 76.7 | 40 | <0.01 |
Infarct volume (mL) | 21±35 | 159±150 | <0.01 |
Infarct less than age-adjusted target (%) | 85.7 | 19.6 | <0.01 |
ASPECTS, Alberta Stroke Program Early CT score; BP, blood pressure; ICA, internal carotid artery; ICH, intracranial hemorrhage; mRS, modified Rankin Scale; NIHSS, NIH Stroke Scale; TICI, Thrombolysis In Cerebral Infarction; tPA, tissue plasminogen activator.